Oxford Biomedica raises £39m after snapping up majority stake in US firm

Oxford Biomedica, which helped AstraZeneca with its Covid-19 vaccine manufacturing, has raised £39.4m in a share placing. The placing represents 5.6 per cent of the company’s issued share capital to date. The London-listed gene and cell therapy group launched a placing to raise £80m last week, as it looks to widen its viral vector manufacturing [...]